Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Pfizer INC paid sponsored hires in similar roles3 certified filings for “SENIOR SCIENTIST” (Biochemists and Biophysicists) in CT: $120k–$128k, median $128k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles
- 3 certified filings for “SENIOR SCIENTIST” (Biochemists and Biophysicists) in CT: $120k–$128k, median $128k. Most were filed at wage level I (100%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Position Summary
Pfizer is seeking a highly motivated Scientist to join the In Vivo Pharmacology group within the Oncology Research Unit, with a focus on antibody-drug conjugate (ADC) programs, but including other large molecule and small molecule programs. This role supports the execution of high-quality in vivo efficacy, pharmacodynamic, tolerability, and mechanistic studies that enable preclinical discovery and development. The ideal candidate will demonstrate strong technical capability in oncology animal models, careful attention to study details, and a commitment to animal welfare, compliance, and scientific rigor. The Scientist is expected to contribute as a reliable technical and scientific team member while developing increasing independence in study execution, data interpretation, and cross-functional collaboration.
Position Responsibilities
• Execute in vivo oncology studies supporting discovery programs using a variety of in vivo models including human cell line- derived, patient-derived xenograft, syngeneic models as appropriate.
• Perform routine and advanced in vivo procedures, including tumor measurements, body weight monitoring, test article administration (IV, PO, subQ, IP dosing), clinical observations, and sample collection.
• Perform routine in vitro tissue culture procedures
• Support pharmacology studies assessing efficacy, tolerability, pharmacodynamic biomarkers, dose-response relationships, schedule optimization, and combination strategies.
• Prepare, review, and follow study protocols, dosing schedules, randomization plans, and sample collection timelines in alignment with project goals and internal standards.
• Maintain accurate, timely, and compliant study records using electronic data capture systems and approved documentation practices.
• Coordinate with project line leads, vivarium operations, pathology, toxicology translational scientists, bioanalytical, pharmacodynamic and pharmacokinetic teams, and external partners to enable efficient study execution.
• Assist with data quality review, graphical summaries, and interpretation of in vivo study results.
• Ensure all work is conducted in accordance with IACUC protocols, animal welfare expectations, biosafety requirements, and Pfizer internal policies.
Minimum Qualifications / Key Skills
• Bachelor’s degree in biology, pharmacology, animal science, cancer biology, or a related discipline with relevant research experience.
• Hands-on experience conducting rodent in vivo studies in an academic, biotechnology, pharmaceutical, or contract research setting.
• Demonstrated proficiency with tumor implantation, tumor measurement, animal monitoring, dosing (IV, PO, subQ, IP), sample collection, and study documentation.
• Working knowledge of oncology pharmacology concepts, including tumor growth inhibition, response assessment, dose scheduling, tolerability, and pharmacodynamic endpoint collection.
• Ability to follow protocols precisely, recognize technical or animal welfare concerns, and escalate issues appropriately.
• Strong attention to detail, organizational skills, and ability to manage study activities across multiple concurrent programs.
• Effective written and verbal communication skills and ability to work collaboratively in a matrixed scientific environment.
• Application of technical expertise to moderately complex procedures and contribution to troubleshooting under guidance from senior scientists or in vivo study leads.
• Accountability for assigned study activities and contribution to team goals, timelines, and quality expectations.
Preferred Qualifications
• Experience supporting ADC, targeted therapy, immuno-oncology, or combination oncology programs.
• Familiarity with ADC-specific pharmacology considerations such as p
Apply on employer site ↗